Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma

被引:102
作者
Koch, Raphael [1 ]
Demant, Martin [1 ]
Aung, Thiha [1 ]
Diering, Nina [1 ]
Cicholas, Anna [1 ]
Chapuy, Bjoern [2 ]
Wenzel, Dirk [3 ]
Lahmann, Marlen [1 ]
Guentsch, Annemarie [1 ]
Kiecke, Christina [1 ]
Becker, Sabrina [1 ]
Hupfeld, Timo [1 ]
Venkataramani, Vivek [1 ]
Ziepert, Marita [4 ]
Opitz, Lennart [5 ]
Klapper, Wolfram [6 ,7 ]
Truemper, Lorenz [1 ]
Wulf, Gerald G. [1 ]
机构
[1] Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany
[4] Inst Med Informat Stat & Epidemiol, Leipzig, Germany
[5] Funct Genom Ctr Zurich, Zurich, Switzerland
[6] Hematopathol Sect, Kiel, Germany
[7] Lymph Node Registry, Kiel, Germany
关键词
ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; DRUG EFFLUX CAPACITY; BETA-CATENIN; SIDE POPULATION; ELDERLY-PATIENTS; TRANSPORTER A3; GROWTH-FACTORS; CANCER-CELLS; IN-VIVO;
D O I
10.1182/blood-2013-08-523886
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumors are composed of phenotypically heterogeneous cell populations. The non-genomic mechanisms underlying transitions and interactions between cell populations are largely unknown. Here, we show that diffuse large B-cell lymphomas possess a self-organized infrastructure comprising side population (SP) and non-SP cells, where transitions between clonogenic states are modulated by exosome-mediated Wnt signaling. DNA methylation modulated SP-non-SP transitions and was correlated with the reciprocal expressions of Wnt signaling pathway agonist Wnt3a in SP cells and the antagonist secreted frizzled-related protein 4 in non-SP cells. Lymphoma SP cells exhibited autonomous clonogenicity and exported Wnt3a via exosomes to neighboring cells, thus modulating population equilibrium in the tumor.
引用
收藏
页码:2189 / 2198
页数:10
相关论文
共 50 条
[21]   Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment [J].
Danilov, Alexey, V ;
Magagnoli, Massimo ;
Matasar, Matthew J. .
ONCOLOGIST, 2022, 27 (01) :57-66
[22]   Limited-stage diffuse large B-cell lymphoma [J].
Hawkes, Eliza A. ;
Barraclough, Allison ;
Sehn, Laurie H. .
BLOOD, 2022, 139 (06) :822-834
[23]   Contemporary management of diffuse large B-cell lymphoma in Japan [J].
Miura, Katsuhiro ;
Takahashi, Hiromichi ;
Nishimaki-Watanabe, Haruna ;
Hamada, Takashi ;
Uchiike, Akihiro ;
Tsutsumi, Daisuke ;
Ohtake, Shimon ;
Iizuka, Kazuhide ;
Koike, Takashi ;
Kurihara, Kazuya ;
Endo, Toshihide ;
Hayama, Tatsuya ;
Nakagawa, Masaru ;
Iriyama, Noriyoshi ;
Hatta, Yoshihiro ;
Nakamura, Hideki .
EXPERT REVIEW OF ANTICANCER THERAPY, 2025, 25 (05) :551-559
[24]   Genetic and epigenetic determinants of diffuse large B-cell lymphoma [J].
Bakhshi, Tanner J. ;
Georgel, Philippe T. .
BLOOD CANCER JOURNAL, 2020, 10 (12)
[25]   Update on lymphoma management: Diffuse large B-cell NHL [J].
Vose, JM ;
Neumann, M ;
Harris, ME .
HEMATOLOGY, 2005, 10 :10-14
[26]   Therapy for diffuse large B-cell lymphoma: getting personal [J].
Cheson, Bruce D. .
LANCET, 2013, 381 (9880) :1793-1794
[27]   Improving Outcomes for Patients with Diffuse Large B-Cell Lymphoma [J].
Flowers, Christopher R. ;
Sinha, Rajni ;
Vose, Julie M. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2010, 60 (06) :393-408
[28]   Analysis of the coding genome of diffuse large B-cell lymphoma [J].
Pasqualucci, Laura ;
Trifonov, Vladimir ;
Fabbri, Giulia ;
Ma, Jing ;
Rossi, Davide ;
Chiarenza, Annalisa ;
Wells, Victoria A. ;
Grunn, Adina ;
Messina, Monica ;
Elliot, Oliver ;
Chan, Joseph ;
Bhagat, Govind ;
Chadburn, Amy ;
Gaidano, Gianluca ;
Mullighan, Charles G. ;
Rabadan, Raul ;
Dalla-Favera, Riccardo .
NATURE GENETICS, 2011, 43 (09) :830-U33
[29]   Prognostication of diffuse large B-cell lymphoma in the rituximab era [J].
Ninan, Mary J. ;
Wadhwa, Punit D. ;
Gupta, Pankaj .
LEUKEMIA & LYMPHOMA, 2011, 52 (03) :360-373
[30]   Diffuse Large B-Cell Lymphoma in the Older and Frail Patient [J].
Ayers, Emily C. ;
Smith, Sonali M. .
CANCERS, 2025, 17 (05)